Last Updated: August, 2024
Trusted by 200+ Clients
Compare & Choose the Right Report Version for You
How to Order Your Report?
The report provides a detailed analysis essential for establishing a pioglitazone (Actos) production plant. It encompasses all critical aspects necessary for pioglitazone (Actos) production, including the cost of pioglitazone (Actos) production, pioglitazone (Actos) plant cost, pioglitazone (Actos) production costs, and the overall pioglitazone (Actos) production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a pioglitazone (Actos) production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Pioglitazone (Actos) is an FDA-approved medicine that is widely used in the medical and pharmaceutical industries. It is majorly utilized for the management and treatment of type 2 diabetes mellitus. Moreover, it finds its application as medication, along with proper diet and exercise, to regulate blood sugar levels and promote insulin sensitivity. Additionally, it is also employed in several clinical trials to demonstrate its efficacy and enhance its bioavailability.
The market for pioglitazone (Actos) is majorly driven by its broad usage as an antihyperglycemic for regulating blood sugar levels in patients with type 2 diabetes, which significantly promotes its demand in the medical and pharmaceutical industries. Moreover, its application as a medicine solely or in combination with other drugs for managing sugar levels in the blood by lowering insulin resistance further enhances its demand in the pharmaceutical industry.
Additionally, its employment for research activities and clinical trials effectively fuels its demand in the biotechnology and research & development industries. Furthermore, several factors influence industrial pioglitazone procurement, such as the availability of raw materials (Thiazolidine-2,4-dione, etc.), cost and pricing, compliance with medical and pharmaceutical regulations, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.
According to the Pioglitazone (Actos) production plant project report, the major raw materials for Pioglitazone (Actos) production include 4-[2-(5-ethyl-2-pyridinyl)-ethoxy]-Benzaldehyde-Thiazolidine-2,4-dione.
The extensive pioglitazone (Actos) production cost report consists of the following industrial production process:
Pioglitazone (Actos) belongs to the class of thiazolidenediones. The IUPAC name of the compound is 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione. It is used as an anti-diabetic drug. This drug is often recognized by some other names, which include Zactos, Glustin, Piozone, and Pioglitazonum. Moreover, the molecular formula of the compound is C19H20N2O3S, and its molar mass is 356.4 g/mol. Its melting point is 183-184 °C, and it does not dissolve in water. Additionally, the compound, on heating, decomposes and releases hazardous products, including carbon dioxides, sulfur oxides, and nitrogen oxides.
Pioglitazone (Actos) Production Cost Report
Choose What's Right for You
Pay Via
| Particulars | Details |
|---|---|
| Product Name | Pioglitazone (Actos) |
| Scope | Production Process: Process Flow, Material Flow, Material Balance Raw Material and Product Specifications: Raw Material Consumption, Product and Co-product Generation Land and Site Cost: Offsites/Civil Works, Equipment Cost, Auxiliary Equipment Costs, Contingency, Engineering and Consulting Charges, Working Capital Variable Cost: Raw Material, Utilities, Other Variable Costs Fixed Cost: Labor Requirements and Wages, Overhead Expenses, Maintenance Charges, Other Fixed Costs Financing Costs: Interest on Working Capital, Interest on Loans Other Costs: Depreciation Charges, General Sales and Admin Cost |
| Currency | US$ (Data can also be provided in the local currency) |
| Pricing and Purchase Options | Basic: US$ 2499 Premium: US$ 3499 Enterprise: US$ 4799 |
| Customization Scope | The report can be customized as per the requirement of the customer |
| Post-Sale Analysts Report | 10-12 weeks of post-purchase analyst support after report delivery for any queries from the deliverable |
| Delivery Format | PDF and Excel format through email (editable version in PPT/Word format of the report can be also provided on special request) |
At Procurement Resource, we not only focus on optimizing the should cost of production for Pioglitazone (Actos) but also provide our clients with extensive intel and rigorous information on every aspect of the production process. By utilizing a comprehensive cost model, we help you break down expenses related to raw materials, labor, and technology, offering clear pathways to savings. We also assist in evaluating the capital expenditure (CAPEX) and operating expenses (OPEX), which are often measured as cost per unit of production, such as USD/MT, ensuring that your financial planning is aligned with industry benchmarks.
We offer valuable insights on the top technology providers, in-depth supplier database, and best manufacturers, helping you make informed decisions to improve efficiency. Additionally, we design the most feasible layout for your production needs, ensuring the entire process runs smoothly. By minimizing the cash cost of production, we ensure that you stay competitive while securing long-term profitability in the growing Pioglitazone (Actos) market. Partnering with Procurement Resource guarantees that every aspect of your production is cost-efficient, advanced, and tailored to your specific requirements.
Lead - Social & Development Research
Delivering procurement intelligence and supply chain analytics across healthcare, FMCG, and chemicals sectors, with expertise in cost modeling, vendor mapping, and spend optimization to support data-driven sourcing decisions and procurement outcomes.
Need more help?
Still Need Help?
